Nvidia has stepped up the pace of its European investments again. On October 13, 2026, speaking at an event in Paris, Jensen Huang said Nvidia plans to announce roughly $2 billion in new European AI investments within a week, on top of about $8 billion deployed across Europe over the past year. The first moves, announced the same day, are stakes in four French companies — healthcare platform Doctolib, robotics company Genesis AI, business planning software maker Pigment, and materials chemistry company Entalpic — with no amounts or stake sizes disclosed for any of them. Paris was the first stop of Huang's European tour, which continues to London and Berlin and included a meeting with French President Emmanuel Macron.
Four companies, four very different bets
What stands out about the list is how spread out it is. Doctolib is the most mature of the four: it runs medical appointment booking and practice administration used by large numbers of patients in France, Germany and Italy, and is building AI agents to take work off healthcare professionals plus a digital health companion for patients. Doctolib confirmed Nvidia will buy a minority stake, and its leadership says the money will fund hiring and in-house AI models — models that run on Nvidia chips. Genesis AI works on general-purpose robots and the foundation models, simulation and data systems behind them. Pigment makes planning software for finance, sales and workforce forecasting. Entalpic uses AI to accelerate materials and chemistry discovery at the atomic scale, aimed at sectors such as semiconductor manufacturing. The four tracks do not overlap; their one shared trait is that all are AI-native businesses that will keep consuming compute.
Why now, and why Europe
Huang's message in Paris was blunt: Europe needs to get in the race. He also stressed what open models mean for Europe — they can be customised for local languages and data-sovereignty requirements. Nvidia is already a partner and investor in French model developer Mistral AI; spreading bets across healthcare, robotics, software and materials in one move is plainly not only about financial return: every portfolio company that scales becomes a long-term customer for Nvidia chips and platforms. The timing also contrasts with Nvidia's position in China, where its share of AI accelerator shipments has fallen sharply under export controls — a defensive fight over an existing market on one side, and a near-$10 billion cumulative push into a growth market on the other.
The wording deserves care, so plans are not mistaken for completed facts: the $2 billion is an amount Nvidia says it will announce within a week, not money already paid out; none of the four stake sizes is disclosed; and the $8 billion past-year figure and the roughly $10 billion cumulative framing are Nvidia's own numbers, not independently audited. The projects unveiled over the coming week will show what the money actually buys — compute, equity or procurement deals. For Europe's AI ecosystem the signal is still unmistakable: while the region debates how to build sovereign compute, the largest seller of that compute has arrived early with a chequebook, and what it wants is not just orders, but a position at the ecosystem's entrance.
